Tina Garyantes PhD

Tina is the Vice President of Therapeutics at Chromocell responsible for internal and external technology development and scouting for opportunities in new areas. Prior to joining Chromocell, she was CEO of MaxSAR which focused on a high throughput approach to expanding chemical diversity, global head of Assay Development and Screening at Sanofi, particularly Phenotypic and Image Based Screening with therapeutic responsibilities in Fibrosis and Oncology. Tina invented the virtual well plate while at Merck and developed the first clinical instrument for fine structure analysis of DNA at Ciba-Corning Diagnostics